Form 4: Dolby Labs Executive Executes Stock Sale Plan

SVP of Advanced Technology Group Shriram Revankar sold 3,000 shares of Dolby Laboratories stock under a 10b5-1 trading plan.

Summary

• Shriram Revankar, SVP of Advanced Technology Group, sold 3,000 shares of Class A Common Stock at $54.90 per share on May 15, 2026.
• An additional 4,329 shares were withheld by the company on May 18, 2026, at $54.21 per share to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, the reporting person maintains a beneficial ownership of 76,274 shares.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on August 22, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and reflects standard executive financial management rather than a reaction to company performance.

Positives

• The sale was pre-planned under a Rule 10b5-1 trading plan, indicating the transaction was not based on non-public information.

Negatives

• The transaction represents a reduction in the executive's direct equity stake in the company.

Risks

• Future share price volatility may impact the value of remaining restricted stock units held by the executive.

Future Outlook

No specific forward-looking guidance regarding company performance was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is standard corporate practice and generally does not signal a change in management's outlook on the company's long-term prospects.

Comparison to Industry Standards

• The use of 10b5-1 plans is a standard governance practice for executives to liquidate equity positions while maintaining compliance with SEC insider trading regulations.

Stakeholder Impact

• Minimal impact on shareholders as the sale was executed through a pre-established, automated trading plan.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Dolby Laboratories, DLB, Insider Trading, Form 4, Shriram Revankar, 10b5-1